PUNE, India, February 23, 2017 /PRNewswire/ --
According to a new market research report "Influenza
Diagnostics Market Test type (Traditional (Rapid Influenza
Detection Test, Viral Culture, DFA, Serology Test), Molecular
(RT-PCR, NASBA, LAMP, SAMBA)), End user (Hospital, Clinic,
Reference lab, POC, Home Care Agency) - Global Forecast to
2021" published by MarketsandMarkets, the market is expected to
reach USD 767.4 Million by 2021 from
USD 508.0 Million in 2016, at a CAGR
of 8.6% from 2016 to 2021.
(Logo:
http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 91 market data Tables and 33 Figures spread through
127 Pages and in-depth TOC on "Influenza Diagnostics
Market"
http://www.marketsandmarkets.com/Market-Reports/influenza-diagnostic-market-222985562.html
Early buyers will receive 10% customization on this
report.
The report provides a detailed overview of the major drivers,
restraints, opportunities, and threat impacting the Influenza
Diagnostics Market along with the estimates and forecasts of the
revenue and market share analysis. The increasing prevalence of
influenza, growth in research funding for influenza diagnostics,
and rising demand for faster diagnosis and control of influenza are
the major factors that are expected to drive the growth of this
market in the coming years. Also, advancements in technologies such
as PCR and proteomics and significant growth prospects in
developing countries are expected to offer growth opportunities for
players in the Influenza Diagnostics Market.
Inquiry Details:
http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=240573338
The Influenza Diagnostics Market is segmented on the basis of
test type, end user, and region. On the basis of test type, the
market is segmented into traditional diagnostic tests and molecular
diagnostic tests. The traditional diagnostic tests segment is
further divided into rapid influenza detection tests (RIDT), viral
culture, direct fluorescent antibody (DFA) tests, and serological
assays. The molecular diagnostic tests segment is divided into
RT-PCR, nucleic acid sequence-based amplification (NASBA) tests,
loop-mediated isothermal amplification-based assays (LAMP), simple
amplification-based assays (SAMBA), and other tests
(microarray-based approaches and nucleic acid sequencing
approaches). Among these, the traditional diagnostic tests segment
is expected to account for the largest share of the global
Influenza Diagnostics Market in 2016.
On the basis of end user, the market is segmented into
hospitals/clinical laboratories, reference laboratories, and other
end users (point-of-care testing, local public health laboratories,
home health agencies, and nursing homes). The hospitals/clinical
laboratories segment is expected to account for the largest share
of the market in 2016. The large share of this segment can be
attributed to the fact that most influenza disease diagnostic tests
are carried out in hospitals and clinical laboratories, as these
tests are highly complex in nature and require the use of
specialized instruments.
Download PDF Brochure:
http://www.marketsandmarkets.com/pdfdownload.asp?id=240573338
On the basis of region, the market is segmented into
North America, Europe, Asia-Pacific, and RoW. The European market is
expected to account for the largest share of the global Influenza
Diagnostics Market in 2016. The large share of this segment is due
to the increased prevalence of influenza disease and technological
advancements in this region.
The prominent players in the Influenza Diagnostics Market
are Thermo Fisher Scientific (U.S.), Roche Diagnostics
(Switzerland), Alere Inc. (U.S.),
Quidel Corporation (U.S.), Becton, Dickinson and Company (U.S.),
DiaSorin (Italy), SA Scientific
(U.S.), and Luminex Corporation (U.S.).
Browse Related Reports:
Molecular Diagnostics Market by Application (Infectious
Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology),
Technology (PCR, Hybridization, DNA Sequencing), End User
(Hospitals, Laboratory), Product & Service (Reagent, Software)
- Forecast to 2021
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html
Respiratory Diagnostics Market by Product & Service
(Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function
Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User
(Reference Laboratories, Physician Offices) - Global Forecast to
2021
http://www.marketsandmarkets.com/Market-Reports/respiratory-diagnostics-market-163390459.html
About MarketsandMarkets:
MarketsandMarkets is the largest market research firm worldwide
in terms of annually published premium market research reports.
Serving 1700 global fortune enterprises with more than 1200 premium
studies in a year, M&M is catering to a multitude of clients
across 8 different industrial verticals. We specialize in
consulting assignments and business research across high growth
markets, cutting edge technologies and newer applications. Our 850
fulltime analyst and SMEs at MarketsandMarkets are tracking global
high growth markets following the "Growth Engagement Model - GEM".
The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers,
write "Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research
platform, "RT" connects over 200,000 markets and entire value
chains for deeper understanding of the unmet insights along with
market sizing and forecasts of niche markets. The new included
chapters on Methodology and Benchmarking presented with high
quality analytical infographics in our reports gives complete
visibility of how the numbers have been arrived and defend the
accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by
providing apt business insight with our huge market intelligence
repository.
Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @
http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn
@ http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets